2m 2m 2m 2m 2m 2m 2m
SERES THERAPEUTI (MCRB)
NASDAQ
$2.15-$0.15 (-6.57%)
Price as of Oct 22, 2026 7:50 PM EDT- $23.1MMarket Cap
- -87.33%1-Year Change
- BiotechnologyIndustry
SERES THERAPEUTI (MCRB)
$2.15-$0.15 (-6.57%)
MCRB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.30 | ||
Change | -$0.01 (-0.43%) | ||
Open | $2.30 | ||
High | $2.40 | ||
Low | $2.26 | ||
Previous Close | $2.31 | ||
Volume | 41,768 | ||
30-Day Average Volume | 70,882 | ||
1-Week Change | -4.96% | ||
1-Month Change | -43.49% | ||
1-Year Change | -87.33% | ||
3-Year Change | -91.90% | ||
5-Year Change | -98.11% | ||
Fundamentals | |||
Shares Outstanding | 10.0M | ||
Total Assets | $101.6M | ||
Market Cap | $23.1M | ||
Enterprise Value | $11.1M | ||
Period: QTR TTM FY | |||
Revenue | $736,000.00 | ||
Net Income | $4.6M | ||
Free Cash Flow | -$22.4M | ||
EBIT | $4.6M | ||
EBITDA | $5.3M | ||
Net Working Capital | $22.3M | ||
EPS | $0.47 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 1 | ||
P/E | 5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 04/22/2025 | ||
Earnings & Revenue